Pitavastatin (previously known as itavastatin, itabavastin, nisvastatin, NK-104 or NKS-104) was discovered in Japan by Nissan Chemical Industries and developed further by Kowa Pharmaceuticals, Tokyo. Pitavastatin was approved for use in the United States by the FDA on 08/03/2009 under the trade name Livalo.
Pitavastatin (formerly known as itavastatin, itabavastin, nisvastatin, NK-104 or NKS-104) was identified in Japan by Nissan Chemical Industries and advanced by Kowa Pharmaceuticals, Tokyo. Pitavastatin gained FDA approval for use on August 3, 2009 under the trade name Livalo.